Key Highlights
- The Department of Energy has granted approval for the Documented Safety Analysis (DSA) of Oklo’s Groves Isotope Test Reactor located in Lockhart, Texas, representing the final safety checkpoint before activation.
- The facility has advanced to DOE’s concluding pre-startup evaluation stage, with initial criticality scheduled for July 2026.
- This marks the first time an advanced reactor situated on private property has secured DSA clearance, utilizing entirely commercial fuel and hardware sources.
- Shares of OKLO climbed 5% during premarket hours following the announcement; the company maintains a $9.1 billion valuation despite a 27% decline over the previous half-year.
- The Groves installation serves as an isotope production center rather than an energy generator — Oklo’s vision for commercial power generation centers on its Aurora powerhouse concept, which remains under development.
Oklo’s Groves Isotope Test Reactor situated in Lockhart, Texas has successfully navigated a significant regulatory checkpoint. On Wednesday, the U.S. Department of Energy granted approval for the facility’s Documented Safety Analysis, advancing Oklo closer to launching its inaugural reactor.
Shares of OKLO experienced a 5% surge during premarket trading following the announcement. The company maintains a market valuation of $9.1 billion, despite experiencing a 27% downturn over the preceding six months.
The DSA represents the installation’s concluding safety foundation documentation. Following this approval, Groves transitions into the DOE’s terminal pre-startup evaluation stage — an examination encompassing a preparedness assessment and launch authorization before nuclear material loading and experimental procedures can commence.
Oklo has established July 2026 as the target date for achieving first criticality at Groves. First criticality signifies the point when a reactor attains a regulated, self-perpetuating nuclear fission reaction.
The schedule carries significance. Oklo received designation last year for a DOE program aimed at establishing no fewer than three experimental reactors at federal laboratories by Independence Day. The organization confirmed its progress remains aligned with this objective.
Chief Executive Jacob DeWitte characterized the development as a landmark achievement, emphasizing that Groves represents “the first advanced reactor project to receive approval of its Documented Safety Analysis that is on privately owned land, with wholly commercially sourced fuel, equipment, and systems delivered by the private sector.”
The organization initiated construction on the Groves installation under twelve months ago. Development and operational activities have been directed by a commercial-sector team operating under DOE supervision.
Understanding Groves’ Purpose and Function
Clarity regarding Groves’ actual function is essential. The installation operates as an isotope manufacturing center, not an electricity-generating station. It will not produce power for the grid.
Its mission involves manufacturing radioisotopes utilized in cancer detection and therapy, sophisticated manufacturing processes, scientific investigation, space missions, and defense applications. The United States presently relies substantially on international providers and deteriorating domestic installations for these critical materials.
Oklo’s electricity generation objectives are connected to its Aurora powerhouse configuration, a fast fission reactor currently being developed at Idaho National Laboratory. A fuel manufacturing facility is simultaneously under construction at that location. The DOE has previously approved the Preliminary Documented Safety Analysis for the Aurora initiative.
Additional Developments and Strategic Moves
Oklo has demonstrated considerable activity beyond the Groves project. The organization recently completed the acquisition of Creative Engineers, Inc., a company specializing in sodium and alkali-metal technologies.
The company also formalized a Letter of Intent with Centrus Energy Corp. for the procurement of high-assay low-enriched uranium (HALEU) destined for its Aurora powerhouse facility in Ohio, with shipments anticipated to commence in 2029.
Oklo and Standard Nuclear established a memorandum of understanding to investigate nuclear fuel reprocessing and sophisticated fuel production, concentrating on materials from a proposed installation in Oak Ridge, Tennessee.
Guggenheim launched coverage of Oklo with a neutral recommendation, forecasting that EBITDA will achieve positive territory by 2030.
InvestingPro analysis indicates Oklo maintains a stronger cash position than debt obligations on its financial statements. The identical assessment observes the stock appears moderately overvalued compared to its Fair Value calculation.
The subsequent official milestone for Groves involves DOE’s preparedness evaluation and launch authorization before fuel introduction can advance.


